RxDoctor Payments Data

Miles Wei, MD

Internal Medicine · Conyers, GANPI 1750886768

Payments from drug & device makers

$2,868in general payments, 2019–2025

Across 148 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$390
  • AstraZeneca$257
  • Otsuka America Pharmaceutical, Inc.$235
  • AbbVie$218
  • GSK$201
  • Lilly USA, LLC$170
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$2,868100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,868 in reported general payments places this provider in the 80th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$48,574
Medicare patients
134
Services billed
545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide112$120,481
EliquisApixaban50$47,188
MounjaroTirzepatide43$43,384
JardianceEmpagliflozin20$27,667
JanuviaSitagliptin Phosphate25$26,780
TrulicityDulaglutide12$19,292
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,148
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$3,266
SymbicortBudesonide/Formoterol Fumarate14$3,083
Albuterol Sulfate HfaAlbuterol Sulfate60$2,350
Atorvastatin Calcium243$2,311
Novolog FlexpenInsulin Aspart16$2,065
Gabapentin109$1,999
Esomeprazole Magnesium12$1,825
Clonidine18$1,688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$390$120,481112 claims
Lilly USA, LLCMounjaro, Trulicity$170$62,67555 claims
PfizerEliquis$80$47,18850 claims
Boehringer IngelheimJardiance$75$27,66720 claims
MerckJanuvia$14$26,78025 claims
GSKTrelegy Ellipta$201$9,14815 claims
AstraZenecaSymbicort$257$3,08314 claims
AbbVieSynthroid$218$1,41020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,311 internal medicine providers in Georgia.

Other internal medicine in Conyers

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →